Primary Record
Gypenoside XVII
- In stock
- 6,179 g
- Purity
- 98.5 %
- CAS
- 80321-69-3
Compound Identifiers & Properties
- CAS
- 80321-69-3
- PubChem CID
- 44584555
- SMILES
- CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)C)O)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O)O)O)C
- Canonical SMILES
- CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C
Names & Synonyms
- Gypenoside XVII
- GYPENOSIDE-XVII
- Gynosaponin S
- 80321-69-3
- Erianin
- Ginsenoside XVII
- RefChem:144911
- Gyp-17
- Gypenoside XVIIGynosaponin S
- CHEBI:77155
- MFCD10566703
- CHEMBL504441
- DTXSID001317018
- orb1304251
- SCHEMBL26873117
- C48H82O18
- DTXCID801746837
- HMS3887K09
- HY-N0553
- MSK40334
- NP7006
- s9207
- AKOS027251125
- ZINC253387973
- ACN-047101
- CCG-270587
- CS-4163
- EBC-616865
- OG32258
- GYPENOSIDE XVII (REFERENCE GRADE)
- AC-34605
- DA-63988
- MS-31771
- J419.453E
- FT-0777059
- N2767
- Y0100
- C20736
- A1205172
- Q27146716
- (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2S)-2-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol
- (2S,3R,4S,5S,6R)-2-{[(2S)-2-[(1S,3aR,3bR,5aR,7S,9aR,9bR,11R,11aR)-11-hydroxy-3a,3b,6,6,9a-pentamethyl-7-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-en-2-yl]oxy}-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol
- (2R,3R,4S,5S,6R)-2-{[(1S,3AR,3BR,5AR,7S,9AR,9BR,11R,11AR)-11-HYDROXY-3A,3B,6,6,9A-PENTAMETHYL-1-[(2S)-6-METHYL-2-{[(2S,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-({[(2R,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL]OXY}METHYL)OXAN-2-YL]OXY}HEPT-5-EN-2-YL]-DODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-7-YL]OXY}-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL
- (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(((2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-((2S)-2-((3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-3-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-17-yl)-6-methylhept-5-en-2-yl)oxyoxan-2-yl)methoxy)oxane-3,4,5-triol
- (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(1S)-1-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1,5-dimethyl-hex-4-enoxy]tetrahydropyran-2-yl]methoxy]tetrahydropyran-3,4,5-triol
- (3beta,12beta)-20-{[6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl beta-D-glucopyranoside
- (3ss,12ss)-3-(ss-D-Glucopyranosyloxy)-12-hydroxydammar-24-en-20-yl 6-O-ss-D-glucopyranosyl-ss-D-glucopyranoside; ss-D-Glucopyranoside-dammarane Deriv.; 3-O-Glucosylgypenoside LXXV; Ginsenoside Gyp17; Gynosaponin S; GypXVII;
- 20-[(6-O-beta-D-Glucopyranosyl-beta-D-glucopyranosyl)oxy]-12beta-hydroxydammar-24-en-3beta-yl beta-D-glucopyranoside
- 3beta-(beta-D-Glucopyranosyloxy)-12beta-hydroxy-5alpha-dammar-24-en-20-yl 6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside